PLEASANTON, Calif. , Oct. 1, 2024 /PRNewswire/ -- At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy , 10x Genomics, Inc.
(Nasdaq: TXG ), a leader in single cell and spatial biology, shared new details about its upcoming product roadmap and its ongoing strategy to democratize access to single cell analysis. During its Foundational Sponsor talk in the Sept. 29 Technology Showcase, 10x Genomics announced an imminent plan to deliver "single cell for a single cent.
" Through a series of new products and configurations expected to launch this quarter, 10x Genomics intends to deliver mega-scale single cell analysis at a cost as low as $0.01 per cell. 10x Genomics believes its upcoming launches, which enable 2.
5 million cells per run and 5 million cells per kit, will be the most cost effective single cell products available for CRISPR screens, cell atlassing projects and other high-throughput applications. "We know price is an important consideration, both for new researchers embarking on their first single cell experiment and current customers looking to do more – whether that's analyzing more cells or more samples, or running more experiments, more routinely," said Michael Schnall-Levin , Founding Scientist and Chief Technology Officer at 10x Genomics. "By continuing to deliver single cell technologies that offer superior performance and superior economics, we believe we can expand the single cell opportunity, drive widespread adoption and make single ce.